Copyright: ©Author(s) 2026.
World J Nephrol. Sep 25, 2026; 15(3): 120870
Published online Sep 25, 2026. doi: 10.5527/wjn.120870
Published online Sep 25, 2026. doi: 10.5527/wjn.120870
Table 3 Baseline laboratory data of the studied groups, mean ± SD
| Lactulose group (n = 50) | LA group (n = 50) | Control group (n = 50) | P value | 1P value | 2P value | 3P value | |
| Hemoglobin (mg/dL) | 10.52 ± 2.11 | 10.93 ± 1.87 | 10.56 ± 1.94 | 0.22 | 0.09 | 0.17 | 0.18 |
| Platelets (103/μL) | 282.17 ± 55.67 | 271.25 ± 69.56 | 289.20 ± 43.41 | 0.64 | 0.76 | 0.06 | 0.22 |
| Leucocytes (103/μL) | 5.55 ± 2.56 | 5.90 ± 2.33 | 5.09 ± 2.19 | 0.90 | 0.56 | 0.10 | 0.78 |
| Bilirubin (mg/dL) | 1.01 ± 0.50 | 0.99 ± 0.11 | 1.11 ± 0.21 | 0.12 | 0.09 | 0.34 | 0.19 |
| Albumin (g/dL) | 3.33 ± 1.21 | 3.21 ± 0.69 | 3.30 ± 0.87 | 0.38 | 0.73 | 0.69 | 0.28 |
| AST (U/L) | 31.09 ± 2.87 | 30.09 ± 4.56 | 30.66 ± 6.70 | 0.68 | 0.31 | 0.54 | 0.11 |
| ALT (U/L) | 29.45 ± 3.19 | 28.44 ± 4.59 | 24.56 ± 8.33 | 0.09 | 0.57 | 0.50 | 0.75 |
| Urea (mg/dL) | 56.34 ± 5.60 | 53.04 ± 9.97 | 55.67 ± 8.56 | 0.43 | 0.51 | 0.37 | 0.49 |
| Creatinine (mg/dL) | 3.90 ± 1.11 | 4.05 ± 1.22 | 3.88 ± 1.99 | 0.18 | 0.18 | 0.19 | 0.35 |
| ACR | 123.05 ± 25.17 | 113.16 ± 33.93 | 115.07 ± 25.67 | 0.58 | 0.78 | 0.43 | 0.18 |
| eGFR (mL/minute/1.73 m2) | 46.57 ± 9.89 | 48.17 ± 8.64 | 50.45 ± 7.11 | 0.77 | 0.67 | 0.08 | 0.50 |
| Sodium (mmol/L) | 133.15 ± 0.05 | 132.01 ± 0.26 | 133.03 ± 0.84 | 0.10 | 0.78 | 0.45 | 0.22 |
| Potassium (mmol/L) | 4.91 ± 1.33 | 4.82 ± 0.87 | 4.06 ± 1.87 | 0.09 | 0.10 | 0.08 | 0.11 |
| Calcium (mg/dL) | 9.06 ± 1.89 | 9.17 ± 2.31 | 8.93 ± 1.23 | 0.72 | 0.22 | 0.21 | 0.67 |
| Magnesium (mmol/L) | 1.79 ± 0.15 | 1.71 ± 0.99 | 1.81 ± 0.49 | 0.33 | 0.44 | 0.32 | 0.08 |
| Phosphorus (mmol/L) | 4.50 ± 0.81 | 4.93 ± 1.83 | 4.65 ± 1.45 | 0.21 | 0.09 | 0.45 | 0.33 |
| RBS (mg/dL) | 208.08 ± 8511 | 211.17 ± 55.43 | 221.03 ± 27.45 | 0.22 | 0.21 | 0.56 | 0.56 |
| HbA1C (%) | 7.19 ± 1.22 | 7.43 ± 0.70 | 8.01 ± 0.44 | 0.54 | 0.45 | 0.44 | 0.41 |
| Cholesterol (mg/dL) | 203.09 ± 24.56 | 205.15 ± 45.10 | 219.79 ± 45.67 | 0.09 | 0.67 | 0.09 | 0.21 |
| Triglycerides (mg/dL) | 133.94 ± 28.29 | 129.33 ± 33.10 | 135.90 ± 18.11 | 0.20 | 0.11 | 0.67 | 0.98 |
| LDL (mg/dL) | 119.01 ± 24.21 | 122.09 ± 50.43 | 109.81 ± 34.54 | 0.19 | 0.76 | 0.15 | 0.51 |
| HDL (mg/dL) | 48.11 ± 7.66 | 50.45 ± 7.22 | 49.41 ± 5.89 | 0.32 | 0.07 | 0.23 | 0.07 |
- Citation: Mubarak AS, Elshazly A, Mokhtar A, Gadelkareem RA, Azoz NM. Lactulose vs Lactobacillus acidophilus for patients with chronic kidney disease: A randomized controlled trial. World J Nephrol 2026; 15(3): 120870
- URL: https://www.wjgnet.com/2220-6124/full/v15/i3/120870.htm
- DOI: https://dx.doi.org/10.5527/wjn.120870